Zusammenfassung
Defizite in der kognitiven Leistungsfähigkeit zählen zu den Schlüsselsymptomen der Multiplen Sklerose (MS). Prävalenzraten werden je nach Studienlage mit 43 % (Rao et al. 1991a) bis 60 % (Benedict et al. 2006) angegeben. Somit leidet jeder zweite MS-Patient unter Einbußen in der kognitiven Kapazität. Die Defizite können bereits früh im Krankheitsgeschehen auftreten, sind, unabhängig vom Behinderungsgrad, auch bei einer benignen Verlaufsform präsent (Amato et al. 2006) und wirken sich negativ auf die Lebensqualität der Betroffenen aus. Anders als bei demenziellen Erkrankungen ist die Progression der kognitiven Defizite bei MS als eher langsam einzustufen (Amato et al. 2001). Eine möglichst frühzeitige differenzierte und zuverlässige neuropsychologische Diagnostik der sogenannten Kerndefizite unter Mitberücksichtigung möglicher kovariierender Faktoren, wie Fatigue, Depression und Angststörungen, ist von großer klinischer Relevanz.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Achiron A, Barak Y (2006) Cognitive changes in early MS: a call for a common framework. Journal of the Neurological Sciences 245(1–2):47–51
Akbar N, Lobaugh NJ, O’Connor P, Moradzadeh L, Scott CJM, Feinstein A (2010) Diffusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients. Canadian Journal of Neurological Sciences 37:608–14
Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L (1995) Cognitive impairment in early-onset multiple sclerosis: Pattern, predictors, and impact on everyday life in a 4-year follow-up. Archives of Neurology 52:168–72
Amato MP, Ponziani G, Siracusa G, Sorbi S (2001) Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Archives of Neurology 58:1602–6
Amato MP, Zipoli V, Goretti B, Ricchiuti L, De Caro MF, Portaccio E et al (2006) Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. Journal of Neurology 253(8):1054–9
Armstrong C, Onishi K, Robinson K, D’Esposito M, Thompson H et al (1996) Serial position and temporal cue effects in multiple sclerosis: two subtypes of defective memory mechanisms. Neuropsychologia 34:853–62
Arnett PA, Grafman J, Rao SM, Binder JR, Luchetta T, Bernardin L et al (1997) Executive functions in multiple sclerosis: An analysis of temporal ordering, semantic encoding, and planning abilities. Neuropsychology 11:535–44
Audoin B, Au Duong MV, Malikova I, Cozzone PJ, Ibarrola D, Confort-Gouny S et al (2006) Functional magnetic resonance imaging and cognition at the very early stage of MS. Journal of the Neurological Sciences 245:87–91
Audoin B, Ibarrola D, Ranjeva JP, Ali-Cherif A, Malikova I, Confort-Gouny S et al (2003) Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Human Brain Mapping 20:51–8
Beatty WW, Blanco CR, Wilbanks SL, Paul RH, Hames KA (1995) Demographic, clinical, and cognitive characteristics of MS patients who continue to work. Neurorehabilitation and neural repair 9:167–73
Benedict RH (editor) (1997) Brief Visuospatial Memory Test-Revised (BVMT-R). Lutz FL: Psychological Assessment Resources Inc; 1997.
Benedict RH, Carone DA, Bakshi R (2004a) Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. Journal of Neuroimaging 14:36S–45S
Benedict RH, Cookfair DL, Gavett R, Garg N, Munschauer F, Gunther M et al (2006) Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). Journal of the International Neuropsychological Society 12(4):549–58
Benedict RH, Munschauer F, Zarevics P, Feaster T, Rowe V, Erlanger D et al (2008) Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients. Journal of Neurology 255(6):848–52
Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R (2004b) Prediction of neuropsychological impairment in multiple sclerosis. Archives of Neurology 61:226–30
Cader S, Palace J, Matthews PM (2009) Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis. Journal of Psychopharmacology 23(6):686–96
Calabrese M, Agosto F, Rinaldi F, Favaretto A, Grossi P, Mattisi I et al (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Archives of Neurology 66(9):1144–50
Calabrese P, Penner IK (2007) Cognitive dysfunctions in multiple sclerosis − a „multiple disconnection syndrome?“. Journal of Neurology 254:18–21
Chiaravalloti ND, Wylie G, Leavitt V, DeLuca J (2012) Increased cerebral activation after behavioral treatment for memory deficits in M. Journal of Neurology 259(7):1337–46
Colcombe S, Kramer AF (2003) Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychological Science 14(2):125–30
Colcombe SJ, Kramer AF, Erickson KI, Cohen NJ, McAuley E, Scalf P et al (2004) Cardiovascular fitness, cortical plasticity, and aging. Proceedings of the National Academy of Sciences of the United States of America 101:3316–21
Correale J, Ysrraelit MC, Fiol MP (2012) Benign multiple sclerosis: does it exist? Current Neurology and Neuroscience Reports. Epub ahead of print.
Delis DC, Kramer JH, Kaplan E, Ober BA (2000) California Verbal Learning Test, second edition (CVLT-II). San Antonio, TX: Psychological Corporation
Deloire MS, Ruet A, Hamel D, Bonnet M, Dousset V, Brochet B (2011) MRI predictors of cognitive outcome in early multiple sclerosis. Neurology 76(13):1161–7
Deloire MSA, Salort E, Bonnet M, Amieva H, Boudineau M, Arimone Y et al (2005) Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 76:519–26
Dineen RA, Vilisaar J, Hlinka J, Constantinescu CS, Morgan PS, Bradshaw CM et al (2009) Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132:239–49
Feuillet L, Reuter F, Audoin B, Cherif AA, Barrau K, Malikova I et al (2007) Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Multiple Sclerosis 13(1):124–7
Filippi M, Riccitelli G, Mattioli F, Pagani E, Stampatori C, Capra R et al (2012) Multiple sclerosis: effects of cognitive rehabilitation on structural and functional MR imaging measures – an explorative study. Radiology 262(3):932–40
Fischer JS, Priore RL, Jacobs LD, Herndon RM, Rudick RA, Cookfair DL et al (2000) Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Annals of Neurology 48:885–92
Foong J, Rozewicz L, Davie CA, Thompson AJ, Miller DH, Ron MA (1999) Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology. Journal of Neuropsychiatry and Clinical Neuroscience 11(1):45–50
Gadea M, Martinez-Bisbal MC, Marti-Bonmati L, Coret F, Casanova B, Espert R et al (2004) Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis. Brain 127:89–98
Glanz BI, Healy BC, Hviid LE, Chitnis T, Weiner HL (2012) Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. Journal of Neurology Neurosurgery and Psychiatry 83:38–43
Grafman J, Rao SM, Bernardin L, Leo GJ (1991) Automatic memory processes in patients with MS. Archives of Neurology 48:1072–5
Gronwall D (1977) Advances in the assessment of attention and information processing after head injury. In: Levin HS, Grafman J, Eisenberg HM (Hrsg) Neurobehavioral recovery from head injury. Oxford University Press, New York, S 355–71
Harel Y, Appleboim N, Lavie M, Achiron A (2009) Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process. Journal of the Neurological Sciences 276(1–2):38–40
Heaton RK, Nelson LM, Thompson DS, Burks JS, Franklin GM (1985) Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. Journal of Consulting and Clinical Psychology 53:103–10
Jedrziewski MK, Ewbank DC, Wang H, Trojanowski JQ (2010) Exercise and cognition: results from the National Long Term Care Survey. Alzheimer’s and Dementia 6(6):448–55
Khalil M, Enzinger C, Langkammer C, Tscherner M, Loitfelder M, Petrovic K et al (2011) Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Multiple Sclerosis 17(2):173–80
Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE (2004) Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 63:1579–85
Krupp LB, Christodoulou C, Melville P, Muenz LR, Pai LY, Scherl WF et al (2011) Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology 76(17):1500–7
Kujala P, Portin R, Revonsuo A, Ruutiainen J (1994) Automatic and controlled information processing in MS. Brain 117:1115–26
Kutzelnigg A, Lassmann H (2006) Cortical demyelination in multiple sclerosis: A substrate for cognitive deficits? Journal of the Neurological Sciences 245:123–6
Langdon DW, Amato MP, Boringa J, Fredrikson S, Foley F, Brochet B et al (2012) Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Multiple Sclerosis 18(6):891–8
Lebrun C, Blanc F, Brassat D, Zephir H, de Seze J, CFSEP (2010) Cognitive function in radiologically isolated syndrome. Multiple Sclerosis 16(8):919–25
Mäurer M, Ortler S, Baier M, Meergans M, Scherer P, Hofmann W et al. (2012) Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients. Multiple Sclerosis. Epub ahead of print.
McDonald WI, Compston A, Edan G, Lublin FD, Hartung H-P, Goodkin D et al (2001) Recommended diagnostic criteria for Multiple Sclerosis: Guidelines from the international panel on the diagnosis of Multiple Sclerosis. Annals of Neurology 50:121–7
Mesaros S, Rocca MA, Kacar K, Stosic-Opincal T, Copetti M, Kostic J et al (2012) Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis. Neurology 78:969–75
Morrow SA, Kaushik T, Zarevics P, Munschauer FE, Bear MF, Erlanger D et al (2009) The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial. Journal of Neurology 256(7):1095–102
Oken BS, Kishiyama S, Zajdel D, Bourdette D, Haas M, Kraemer DF, Hugos C, Carlsen J et al (2004) Randomized controlled trial of yoga and exercise in multipe sclerosis. Neurology 62(11):2058–64
Patti F, Amato MP, Bastianello S, Ferrazza P, Di Monte E, Caniatti L et al (2010) Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis 16(1):68–77
Patti F, Amato MP, Trojano M, Picconi O, Tola MR, Bastianello S et al (2012) Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II). Quality of Life Research 21(7):1111–21
Penner IK, Kappos L, Rausch M, Opwis K, Radü EW (2006b) Therapy-induced plasticity of cognitive functions in MS patients: Insights from fMRI. Journal of Physiology Paris 99:455–62
Penner IK, Kobel M, Opwis K (2006) BrainStim – A recently developed tool to train different aspects of working memory. Proceedings of the INS/GNP Conference 2006a:17–8
Penner IK, Opwis K, Kappos L (2007) Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis. Journal of Neurology 254(Suppl2):53–7
Penner IK, Rausch M, Kappos L, Opwis K, Radü EW (2003) Analysis of impairment related functional architecture in MS patients during performance of different attention tasks. Journal of Neurology 250:461–72
Penner IK, Stemper B, Calabrese P, Edan G, Polman CH, Freedman MS et al (2012) Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis. Multiple Sclerosis 18(10):1466–71
Portaccio E, Stromillo ML, Goretti B, Battaglini M, Siracusa G, Zipoli V et al (2009) Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 73(7):498–503
Potagas C, Giogkaraki E, Koutsis G, Sfagos C, Tsirempolou E, Mandellos D et al (2008) Cognitive impairment in different MS subtypes and clinically isolated syndromes. Journal of the Neurological Sciences 267(1–2):100–6
Prakash RS, Snook EM, Erickson KI, Motl RW, Voss MW, Colcombe SJ et al (2007) Cardiorespiratory fitness: A predictor of cortical plasticity in multiple sclerosis. NeuroImage 34(3):1238–44
Pujol J, Vendrell P, Deus J, Marti-Vilalta JL, Bello J, Junqué C et al (2001) The effect of medial frontal and posterior parietal demyelinating lesions on Stroop interference. NeuroImage 13:68–75
Rao SM, Cognitive Function Study Group (1990) A manual for the brief, repeatable battery of neuropsychological tests in Multiple Sclerosis. Medical College of Wisconsin, Milwaukee
Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991a) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685–91
Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F (1991b) Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41:692–6
Reuter F, Zaaraoui W, Crespy L, Malikova I, Rico A, Faivre A et al (2011a) Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location. Multiple Sclerosis 17(6):755–8
Reuter F, Zaaraoui W, Crespy L, Malikova I, Rico A, Faivre A et al (2011b) Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 82(10):1157–9
Romberg A, Virtanen A, Ruutiainen J (2005) Long-term exercise improves functional impairment but not quality of life in multiple sclerosis. Journal of Neurology 252(7):839–45
Roosendaal SD, Moraal B, Pouwels PJ, Barkhof F, Castelijns JA, Vrenken H et al (2009) Accumulation of cortical lesions in MS: relation with cognitive impairment. Multiple Sclerosis 15(6):708–14
Rovaris M, Iannucci G, Falautano M, Comi G, Martinelli V, Possa F et al (2002) Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: An exploratory study with diffusion tensor MR imaging. Journal of the Neurological Sciences 195:103–9
Sastre-Garriga J, Alonso J, Renom M, Galan I, Gonzalez I, Arévalo MJ et al (2011) A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis. Multiple Sclerosis 17(4):457–67
Scherer P, Penner IK, Rohr A, Wilke-Burger H, Ringel I, Boldt H et al (2007) The Faces Symbol Test: a newly developed sensitive neuropsychological screening instrument for cognitive decline related to multiple sclerosis – first results of the Berlin Multi-Centre FST Validation Study. Multiple Sclerosis 13:402–11
Smith A (1973) Symbol Digit Modalities Test. Los Angeles: Western Psychological Services
Sperling RA, Guttmann CR, Hohol MJ, Parente M, Jakab M, Warfield SK et al (2001) Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis. Archives of Neurology 58:115–21
Sumowski JF, Chiaravalloti ND, Erlanger D, Kaushik T, Benedict RH, DeLuca J (2011) L-amphetamine improves memory in MS patients with objective memory impairment. Multiple Sclerosis 17(9):1141–5
Tiemann L, Penner IK, Haupts M, Schlegel U, Calabrese P (2009) Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns. Multiple Sclerosis 15(10):1164–74
Vogt A, Kappos L, Calabrese P, Opwis K, Gschwind L, Stöcklin M et al (2009) Working memory training in patients with multiple sclerosis – comparison of two different training schedules. Restorative Neurology and Neuroscience 27:225–35
Yu HJ, Christodoulou C, Bhise V, Greenblatt D, Patel Y, Serafin D et al (2011) Multiple white matter tract abnormalities undelrie cognitive impairment in RRMS. NeuroImage 59:3713–22
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Penner, IK. (2013). Kognition. In: Berger, T., Linnebank, M., Wiendl, H. (eds) Betaferon®. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1766-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1766-8_10
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1765-1
Online ISBN: 978-3-7091-1766-8
eBook Packages: Medicine (German Language)